Cargando…
Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A
The aim of this study is to assess the effectiveness of treatment with BTX-A in quality of life of patients suffering from primary focal hyperhidrosis. Materials and Methods. A total of 119 patients (62 females and 57 males) between 18 and 65 years suffering from moderate to severe focal hyperhidros...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932825/ https://www.ncbi.nlm.nih.gov/pubmed/24891956 http://dx.doi.org/10.1155/2014/308650 |
_version_ | 1782304841904685056 |
---|---|
author | Kouris, Anargyros Armyra, Kalliopi Christodoulou, Christos Karimali, Polixeni Karypidis, Dimitrios Kontochristopoulos, George |
author_facet | Kouris, Anargyros Armyra, Kalliopi Christodoulou, Christos Karimali, Polixeni Karypidis, Dimitrios Kontochristopoulos, George |
author_sort | Kouris, Anargyros |
collection | PubMed |
description | The aim of this study is to assess the effectiveness of treatment with BTX-A in quality of life of patients suffering from primary focal hyperhidrosis. Materials and Methods. A total of 119 patients (62 females and 57 males) between 18 and 65 years suffering from moderate to severe focal hyperhidrosis were treated with BTX-A. Thirty-nine patients suffered from axillary hyperhidrosis, 47 patients from palmar hyperhidrosis, 12 patients from plantar hyperhidrosis, and 21 patients from palmar and plantar hyperhidrosis. A baseline and posttreated examination of patients 6 months after BTX-A is included. The Hyperhidrosis Disease Severity Scale (HDSS) was chosen to assess the disease severity and the modified Dermatology Life Quality Index was used (DLQI) to assess the quality of life. Results. Quality of life showed a significant improvement after treatment with BTX-A. The total DLQI score resulted significantly lower than the basal value (P < 0.0001). The seriousness of hyperhidrosis significantly decreased after the treatment (P < 0.0001). In addition, there was notable difference between the posttreatment DLQI scores and pretreatment severity of hyperhidrosis by sex. Conclusions. Treatment with BTX-A led to the reduction of disease severity and improvement of quality of life, while it is a safe, easy to use method with minimal side effects. |
format | Online Article Text |
id | pubmed-3932825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-39328252014-06-02 Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A Kouris, Anargyros Armyra, Kalliopi Christodoulou, Christos Karimali, Polixeni Karypidis, Dimitrios Kontochristopoulos, George ISRN Dermatol Clinical Study The aim of this study is to assess the effectiveness of treatment with BTX-A in quality of life of patients suffering from primary focal hyperhidrosis. Materials and Methods. A total of 119 patients (62 females and 57 males) between 18 and 65 years suffering from moderate to severe focal hyperhidrosis were treated with BTX-A. Thirty-nine patients suffered from axillary hyperhidrosis, 47 patients from palmar hyperhidrosis, 12 patients from plantar hyperhidrosis, and 21 patients from palmar and plantar hyperhidrosis. A baseline and posttreated examination of patients 6 months after BTX-A is included. The Hyperhidrosis Disease Severity Scale (HDSS) was chosen to assess the disease severity and the modified Dermatology Life Quality Index was used (DLQI) to assess the quality of life. Results. Quality of life showed a significant improvement after treatment with BTX-A. The total DLQI score resulted significantly lower than the basal value (P < 0.0001). The seriousness of hyperhidrosis significantly decreased after the treatment (P < 0.0001). In addition, there was notable difference between the posttreatment DLQI scores and pretreatment severity of hyperhidrosis by sex. Conclusions. Treatment with BTX-A led to the reduction of disease severity and improvement of quality of life, while it is a safe, easy to use method with minimal side effects. Hindawi Publishing Corporation 2014-02-06 /pmc/articles/PMC3932825/ /pubmed/24891956 http://dx.doi.org/10.1155/2014/308650 Text en Copyright © 2014 Anargyros Kouris et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Kouris, Anargyros Armyra, Kalliopi Christodoulou, Christos Karimali, Polixeni Karypidis, Dimitrios Kontochristopoulos, George Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A |
title | Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A |
title_full | Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A |
title_fullStr | Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A |
title_full_unstemmed | Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A |
title_short | Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A |
title_sort | quality of life in patients with focal hyperhidrosis before and after treatment with botulinum toxin a |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932825/ https://www.ncbi.nlm.nih.gov/pubmed/24891956 http://dx.doi.org/10.1155/2014/308650 |
work_keys_str_mv | AT kourisanargyros qualityoflifeinpatientswithfocalhyperhidrosisbeforeandaftertreatmentwithbotulinumtoxina AT armyrakalliopi qualityoflifeinpatientswithfocalhyperhidrosisbeforeandaftertreatmentwithbotulinumtoxina AT christodoulouchristos qualityoflifeinpatientswithfocalhyperhidrosisbeforeandaftertreatmentwithbotulinumtoxina AT karimalipolixeni qualityoflifeinpatientswithfocalhyperhidrosisbeforeandaftertreatmentwithbotulinumtoxina AT karypidisdimitrios qualityoflifeinpatientswithfocalhyperhidrosisbeforeandaftertreatmentwithbotulinumtoxina AT kontochristopoulosgeorge qualityoflifeinpatientswithfocalhyperhidrosisbeforeandaftertreatmentwithbotulinumtoxina |